Upon recommendation by underwriters’ counsel, members of CRA’s accounting and advisory team assisted a US-based bio-technology company in advance of its IPO by advising on existing compliance procedures, tightening financial controls, and enhancing internal reporting, governance, and risk management functions. CRA team members recommended and implemented both qualitative and systems-based solutions designed to address regulatory requirements.
End of Lava Jato discredits political and legal stability in the country
In a recent article published by ESTADÃO, Risk, Investigations & Analytics Cynthia Catlett talks about the decision by Federal Supreme Court judge Dias Toffoli...